financetom
Business
financetom
/
Business
/
Top Premarket Gainers
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top Premarket Gainers
Nov 4, 2024 11:39 AM

07:28 AM EST, 11/04/2024 (MT Newswires) -- Nuwellis ( NUWE ) shares soared more than 76% pre-bell Monday after the company said late Friday its pediatric revenue grew 28% year over year in Q3.

Vast Renewables ( VSTE ) shares surged 66%, extending Friday's rally.

Singular Genomics Systems ( OMIC ) shares increased 59% following a 1.1% gain in the previous session.

Air Transport Services Group ( ATSG ) shares were up 22% following a media report that the company is in advanced talks to be acquired by Stonepeak for about $3.1 billion.

Price: 2.4000, Change: +1.04, Percent Change: +76.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Esperion Therapeutics Shares Fall After Reporting Wider Than Expected Q2 Loss
Esperion Therapeutics Shares Fall After Reporting Wider Than Expected Q2 Loss
Aug 12, 2024
03:45 PM EDT, 08/12/2024 (MT Newswires) -- Esperion Therapeutics ( ESPR ) shares were down nearly 8% in recent Monday trading after the company reported a wider-than-expected Q2 net loss. The company reported a Q2 net loss of $0.33 per diluted share, compared with a loss of $0.46 a year earlier. Analysts polled by Capital IQ expected a $0.18 loss....
Update: Eli Lilly Looking to Issue Debt for Morphic Acquisition
Update: Eli Lilly Looking to Issue Debt for Morphic Acquisition
Aug 12, 2024
03:45 PM EDT, 08/12/2024 (MT Newswires) -- (Updates to reflect Eli Lilly ( LLY ) declined comment to MT Newswires) Eli Lilly ( LLY ) filed a prospectus Monday to raise debt for its $3.2 billion acquisition of Morphic. According to a securities filing, the pharma company is looking to issue five separate series of notes to raise $5 billion...
Novartis loses initial bid to block generic of best-selling heart drug
Novartis loses initial bid to block generic of best-selling heart drug
Aug 12, 2024
Aug 12 (Reuters) - Novartis failed to convince a Delaware federal court to block generic drugmaker MSN Pharmaceuticals from launching its own version of Novartis' blockbuster heart-failure drug Entresto, according to a court decision issued on Monday. U.S. District Judge Richard Andrews ruled that Novartis' chance of winning its patent-infringement lawsuit challenging the generic was too low to justify halting...
Portillo's Insider Sold Shares Worth $679,675, According to a Recent SEC Filing
Portillo's Insider Sold Shares Worth $679,675, According to a Recent SEC Filing
Aug 12, 2024
03:56 PM EDT, 08/12/2024 (MT Newswires) -- Michael Osanloo, Director, President & CEO, on August 09, 2024, sold 66,052 shares in Portillo's (PTLO) for $679,675. Following the Form 4 filing with the SEC, Osanloo has control over a total of 79,041 shares of the company, with 79,041 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1871509/000187150924000105/xslF345X03/wk-form4_1723492418.xml Price: 10.82, Change: +0.11, Percent Change: +1.03...
Copyright 2023-2026 - www.financetom.com All Rights Reserved